Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
about
Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signalingNonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up studyHigh expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancerChemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic miceCyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinomaThe relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.Regulation of the prostaglandin pathway during development of invasive bladder cancer in miceRole of the prostaglandin pathway and the use of NSAIDs in genitourinary malignancies.Inflammation and cancer: how friendly is the relationship for cancer patients?Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase.Immunohistochemical Analysis of Cyclooxygenase-2 in Non-Melanocytic Skin Cancer: Correlation With Morphological Subtype and Histologic Grade.Non-invasive detection of bladder cancer via expression-targeted gene delivery.Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
P2860
Q24798655-7C627B6A-5D44-49AA-8441-72FCB30AD158Q28218868-642913FF-D2B4-42CF-BA6B-2F40B7140E8BQ34630311-B9D35128-4177-4995-9285-AE415507EE3BQ35027361-804B4340-A048-4819-A579-44354F6B326BQ36232504-4134EE99-282C-4478-9746-3221932B87AAQ36480350-04C5D09E-16D5-4BE4-8B1E-CD69854E12E3Q36611805-722AFB61-0927-4592-A5C2-174A76D5782BQ37041680-32D23D4D-150A-4CA0-9249-E3A666A02DB5Q37202773-1D17B9F1-FDE8-42E2-A814-7EE155DE55C6Q37316105-4CB813F8-07D7-49BF-B6A2-82EFC346F52FQ38413564-82DF8071-E83D-46BD-8092-8DB806E3C59AQ40524016-E36F9B1D-9361-4E35-8293-A099B3FEB984Q44919731-73818DCD-CE1B-4216-942D-81AFB66261C0Q47901349-90F66287-60A0-47BC-B33E-79524A252914Q51738913-10D1F65F-CD79-436D-99A5-46AC59041839Q53093929-AF80D2D3-18A6-4E1C-A69A-EB56668302F1
P2860
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Correlation of cyclooxygenase- ...... cell carcinoma of the bladder.
@en
type
label
Correlation of cyclooxygenase- ...... cell carcinoma of the bladder.
@en
prefLabel
Correlation of cyclooxygenase- ...... cell carcinoma of the bladder.
@en
P2093
P1476
Correlation of cyclooxygenase- ...... cell carcinoma of the bladder.
@en
P2093
Gustavo E Ayala
JaHong Kim
Jain-Hua Zhou
Kazumasa Matsumoto
Seth P Lerner
Shanrokh F Shariat
Weiguo Jian
William F Benedict
P304
P356
10.1097/01.JU.0000080401.85145.EE
P407
P577
2003-09-01T00:00:00Z